SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Decoding diabetic kidney disease

DECODE-DKD aims to identify novel drug targets for diabetic kidney disease through patient-centric multi-omic research and in-vitro models, advancing precision medicine and treatment options.

Subsidie
€ 1.783.319
2022

Projectdetails

Introduction

Diabetic kidney disease (DKD) is a rapidly growing worldwide health problem and represents one of the most serious threats in current medicine. DKD is the most common cause of chronic kidney disease (CKD) with 20% of DKD patients progressing to end-stage renal disease, which is associated with tremendously increased morbidity and mortality.

Pathophysiology and Treatment Options

The pathophysiology of DKD is complex and incompletely understood, and the number of treatment options is low. The vision of DECODE-DKD is to utilize a patient-centric research approach to identify novel pathways and druggable targets in patients suffering from DKD.

Objectives

Concrete objectives are:

  1. To establish a spatially resolved multi-omic landscape of human DKD.
  2. To dissect and identify therapeutic pathways and signalling networks for novel drug target identification.
  3. To incorporate patient-derived in-vitro models for target validation.

Methodology

It is envisaged that novel spatial and single-cell multi-omic technologies will generate a blueprint and predictive model of DKD. This unbiased map will serve to generate testable hypotheses with spatial and temporal coordinates at single-cell resolution.

To identify disease-relevant pathways and novel druggable targets, in-vitro and in-vivo genome editing approaches will be employed, combined with high-throughput screens. In-vitro assays with human-derived kidney organoids will be used to screen potential compounds facilitating the development of novel therapeutics.

Collaboration and Impact

This highly ambitious interdisciplinary proposal requires the expertise of biomedical engineers, computational biologists, biomedical researchers, and physician-scientists. The generated knowledge and outcomes of DECODE-DKD will - alone and especially together - be truly transformative and provide an incremental step forward towards novel drug targets and precision medicine for the treatment of diabetic kidney disease using a systems medicine approach.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.783.319
Totale projectbegroting€ 1.783.319

Tijdlijn

Startdatum1-4-2022
Einddatum31-3-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • UNIVERSITAETSKLINIKUM AACHENpenvoerder

Land(en)

Germany

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Identification of novel diagnostic, predictive and therapeutic strategies in chronic kidney disease

TargetCKD aims to revolutionize chronic kidney disease management by developing noninvasive diagnostics and novel therapeutics through advanced genomic technologies and interdisciplinary research.

ERC Consolid...€ 1.999.063
2022
Details

Deciphering the genetic basis of chronic kidney disease towards prevention and personalized therapy

This project aims to uncover the genetic basis of chronic kidney disease (CKD) through next-generation sequencing and develop RNA-based therapies for targeted treatment and improved management.

ERC Starting...€ 1.800.000
2022
Details

Early detection, molecular mechanisms and therapeutic interventions in chronic kidney disease

ELIMINATE-CKD aims to enhance chronic kidney disease detection by developing a method to quantify nephron number using multi-omics and machine learning for improved diagnostics and therapies.

ERC Consolid...€ 2.000.000
2024
Details

GenomeDia: a personalized medicine tool for diabetes

The project aims to develop a genetic interpretation tool to subcategorize young diabetes patients, enhancing treatment by leveraging findings from whole genome sequencing.

ERC Proof of...€ 150.000
2024
Details

Developing RNA-editing based therapy for renal cystic ciliopathies

This project aims to demonstrate that RNA editing can correct a pathogenic WDR19 mutation in kidney organoids, potentially leading to new therapies for genetic kidney diseases.

ERC Proof of...€ 150.000
2025
Details
ERC Consolid...

Identification of novel diagnostic, predictive and therapeutic strategies in chronic kidney disease

TargetCKD aims to revolutionize chronic kidney disease management by developing noninvasive diagnostics and novel therapeutics through advanced genomic technologies and interdisciplinary research.

ERC Consolidator Grant
€ 1.999.063
2022
Details
ERC Starting...

Deciphering the genetic basis of chronic kidney disease towards prevention and personalized therapy

This project aims to uncover the genetic basis of chronic kidney disease (CKD) through next-generation sequencing and develop RNA-based therapies for targeted treatment and improved management.

ERC Starting Grant
€ 1.800.000
2022
Details
ERC Consolid...

Early detection, molecular mechanisms and therapeutic interventions in chronic kidney disease

ELIMINATE-CKD aims to enhance chronic kidney disease detection by developing a method to quantify nephron number using multi-omics and machine learning for improved diagnostics and therapies.

ERC Consolidator Grant
€ 2.000.000
2024
Details
ERC Proof of...

GenomeDia: a personalized medicine tool for diabetes

The project aims to develop a genetic interpretation tool to subcategorize young diabetes patients, enhancing treatment by leveraging findings from whole genome sequencing.

ERC Proof of Concept
€ 150.000
2024
Details
ERC Proof of...

Developing RNA-editing based therapy for renal cystic ciliopathies

This project aims to demonstrate that RNA editing can correct a pathogenic WDR19 mutation in kidney organoids, potentially leading to new therapies for genetic kidney diseases.

ERC Proof of Concept
€ 150.000
2025
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Ontwikkeling van een diagnostische test voor de vroege detectie van chronische nierschade

Dit project onderzoekt de ontwikkeling van een niet-invasieve test voor de vroege detectie van chronische nierschade.

Mkb-innovati...€ 18.067
2024
Details

Kidney Disease Sweat sensor patch for Early diagnosis and Remote MonIToring

The KERMIT project aims to develop a cost-effective, disposable sweat patch for non-invasive early detection and remote monitoring of chronic kidney disease biomarkers.

EIC Pathfinder€ 3.080.623
2023
Details

breakthrough technologies for an implantable artificial kidney

KIDNEW aims to develop a modular implantable artificial kidney using innovative technologies for improved, cost-effective kidney replacement therapy without immunosuppressive drugs.

EIC Pathfinder€ 3.293.227
2023
Details

Haalbaarheid Renal Tracker+

Het project onderzoekt de haalbaarheid van de Renal Tracker+, een serviceproduct dat nierpatiënten helpt om de impact van levensstijlveranderingen op hun ziekte te monitoren.

Mkb-innovati...€ 20.000
2020
Details

Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families.

The DCM-NEXT consortium aims to enhance genetic testing and develop novel therapies for dilated cardiomyopathy by leveraging extensive clinical and omics data from 11,750 patients.

EIC Pathfinder€ 4.137.668
2023
Details
Mkb-innovati...

Ontwikkeling van een diagnostische test voor de vroege detectie van chronische nierschade

Dit project onderzoekt de ontwikkeling van een niet-invasieve test voor de vroege detectie van chronische nierschade.

Mkb-innovatiestimulering Topsectoren Haalbaarheid
€ 18.067
2024
Details
EIC Pathfinder

Kidney Disease Sweat sensor patch for Early diagnosis and Remote MonIToring

The KERMIT project aims to develop a cost-effective, disposable sweat patch for non-invasive early detection and remote monitoring of chronic kidney disease biomarkers.

EIC Pathfinder
€ 3.080.623
2023
Details
EIC Pathfinder

breakthrough technologies for an implantable artificial kidney

KIDNEW aims to develop a modular implantable artificial kidney using innovative technologies for improved, cost-effective kidney replacement therapy without immunosuppressive drugs.

EIC Pathfinder
€ 3.293.227
2023
Details
Mkb-innovati...

Haalbaarheid Renal Tracker+

Het project onderzoekt de haalbaarheid van de Renal Tracker+, een serviceproduct dat nierpatiënten helpt om de impact van levensstijlveranderingen op hun ziekte te monitoren.

Mkb-innovatiestimulering Topsectoren Haalbaarheid
€ 20.000
2020
Details
EIC Pathfinder

Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families.

The DCM-NEXT consortium aims to enhance genetic testing and develop novel therapies for dilated cardiomyopathy by leveraging extensive clinical and omics data from 11,750 patients.

EIC Pathfinder
€ 4.137.668
2023
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.